Back to VANGUARD GROUP INC VANGUARD GROUP INC

MYGNMYGN
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in MYRIAD GENETICS INC

As of its last 13F, for Q4 2025, Vanguard Group held 8,225,371 shares of MYGN (Myriad Genetics), worth $50.6M. It increased the position by 342,856 shares (+4.4%) from Q3 2025. Vanguard Group held MYGN from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$50.6M

Current Shares

8.2M

Total Value Change

-$231.9M

Total Shares Change

-2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
8.2M
+4.3%
$50.6M0.0%$6.15
31
2025-Q3
Decreased
7.9M
-14.8%
$57M0.0%$7.23
0
2025-Q2
Decreased
9.3M
-13.2%
$49.2M0.0%$5.31
0
2025-Q1
Increased
10.7M
+0.7%
$94.6M0.0%$8.87
30
2024-Q4
Increased
10.6M
+2.7%
$145.2M0.0%$13.71
31
2024-Q3
First report
10.3M
-
$282.4M0.0%$27.39
0

Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used